Micrornas and drug resistance in non-small cell lung cancer: where are we now and where are we going

HIGHLIGHTS

• who: Roberto Cuttano et al. from the Unit of Biomarkers, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy have published the research work: MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going, in the Journal: Cancers 2022, 14, 5731. of /2022/
• what: Below, the authors provide a schematic report: Cisplatin import/export: regulation of cisplatin import/export is an important mechanism of resistance to cisplatin.
• how: Next the authors analyzed miRNA expression regulation in the drug-resistant condition and the various . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.